Previous close | 35.75 |
Open | 36.12 |
Bid | 37.20 x 900 |
Ask | 37.28 x 1800 |
Day's range | 36.12 - 38.70 |
52-week range | 20.24 - 56.80 |
Volume | |
Avg. volume | 647,009 |
Market cap | 4.547B |
Beta (5Y monthly) | 1.66 |
PE ratio (TTM) | 157.75 |
EPS (TTM) | 0.24 |
Earnings date | 02 May 2022 - 06 May 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 71.08 |
Denali Therapeutics Inc. (DNLI) delivered earnings and revenue surprises of 7.69% and 15.73%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Vertex (VRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Denali Therapeutics Inc. (DNLI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.